"I Made Myself Older By Mistake" - Dr Brad Reacts
Brad Stanfield
Apr 2, 2025
Episode description
Bryan Johnson's video: https://youtu.be/MizVGCELs9Q?si=27dvLRPH-7jNcatp
For weekly health research summaries and extra insights, sign up here 👉 https://drstanfield.com/pages/sign-up
💊 Supplements I Take: https://drstanfield.com/pages/my-supplements
💊MicroVitamin+ (Pro) Powder: https://drstanfield.com/products/microvitamin-plus
💊MicroVitamin Standard Capsules: https://drstanfield.com/products/microvitamin
📜 Roadmap - how to look young & feel strong: https://drstanfield.com/pages/roadmap
✔️ Twitter: https://twitter.com/BradStanfieldMD
✔️ Patreon: https://www.patreon.com/bradstanfieldmd
Video edited by Troy Young
The links above are affiliate links, so I receive a small commission every time you use them to purchase a product. The content contained in this video, and its accompanying description, is not intended to replace viewers’ relationships with their own medical practitioner. Always speak with your doctor regarding the content of this channel, and especially before using any products, services, or devices discussed on this channel.
Mindsip insights from this episode:
Prioritize hard health outcomes in longevity research
Instead of focusing on biological age markers, longevity research should prioritize 'hard outcomes' like actual death rates, cancer rates, and cardiovascular disease rates.
Understand medical evidence hierarchy for informed clinical recommendations
Medical evidence has a hierarchy, with self-experimentation case studies at the bottom and large randomized clinical trials and systematic reviews at the top, which should be the basis for clinical recommendations.
Address funding challenges for Rapamycin clinical trials
Funding for human clinical trials on Rapamycin is difficult to secure because the drug cannot be patented, offering no financial incentive for pharmaceutical companies.
Balance rapamycin dosage to manage immune risks
Rapamycin has a significant risk profile as it suppresses the immune system and specifically the natural killer (NK) cells that fight cancer, making the dosage extremely important.
Trust preclinical data from Interventions Testing Program for reliable results
The Interventions Testing Program (ITP) provides highly reliable preclinical data on drugs like Rapamycin because it runs the same experiment in three separate labs simultaneously to ensure the results are reproducible.
Avoid reliance on unvalidated biological age tests for health decisions
Biological age test kits are interesting research tools, but they are not clinically validated to predict health outcomes like cancer or death and shouldn't be used to make personal health decisions.
Choose Sirolimus for selective mTORC1 targeting to minimize side effects
The form of Rapamycin used is critical, as Sirolimus is more selective for the mTORC1 pathway, while Everolimus targets both mTORC1 and mTORC2, the latter of which is linked to more side effects.
